Surrozen, Inc./DE Investment Income, Interest
Surrozen, Inc./DE (SRZN) reported Investment Income, Interest of $938.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- Surrozen, Inc./DE investment income, interest for the quarter ending 2026-06-30 was $938.00K, a 8.49% decline year-over-year.
- Surrozen, Inc./DE investment income, interest for the quarter ending 2026-03-31 was $912.00K, a 208.11% increase year-over-year.
- Surrozen, Inc./DE investment income, interest for the quarter ending 2025-12-31 was $788.00K, a 103.62% increase year-over-year.
- Surrozen, Inc./DE investment income, interest for the quarter ending 2025-09-30 was $911.00K, a 111.37% increase year-over-year.
- Surrozen, Inc./DE investment income, interest for fiscal 2025 was $3.02M, a 78.38% increase from fiscal 2024.
- Surrozen, Inc./DE investment income, interest for fiscal 2024 was $1.69M, a 27.65% decline from fiscal 2023.
- Surrozen, Inc./DE investment income, interest for fiscal 2023 was $2.34M, a 199.62% increase from fiscal 2022.
- Surrozen, Inc./DE investment income, interest for fiscal 2022 was $781.00K, a 984.72% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 4 month | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $938.00K 10-Q · filed 2026-08-06 | $1.85M 10-Q · filed 2026-08-06 | $2.64M derived: sum of 3 quarters · filed 2026-08-06 | $3.55M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $912.00K 10-Q · filed 2026-05-06 | $1.70M derived: sum of 2 quarters · filed 2026-05-06 | $2.61M derived: sum of 3 quarters · filed 2026-05-06 | $3.64M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $1.70M derived: sum of 2 quarters · filed 2026-03-23 | $2.72M derived: sum of 3 quarters · filed 2026-08-06 | $3.02M 10-K · filed 2026-03-23 | |||
| 2025-09-30 | $911.00K 10-Q · filed 2025-11-07 | $1.94M derived: sum of 2 quarters · filed 2026-08-06 | $2.23M 10-Q · filed 2025-11-07 | $2.62M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $1.02M 10-Q · filed 2026-08-06 | $1.32M 10-Q · filed 2026-08-06 | $1.71M derived: sum of 3 quarters · filed 2026-08-06 | $2.14M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $296.00K 10-Q · filed 2026-05-06 | $683.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.11M derived: sum of 3 quarters · filed 2026-05-06 | $1.60M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $818.00K derived: sum of 2 quarters · filed 2026-03-23 | $1.31M derived: sum of 3 quarters · filed 2026-03-23 | $1.69M 10-K · filed 2026-03-23 | |||
| 2024-09-30 | $431.00K 10-Q · filed 2025-11-07 | $921.00K derived: sum of 2 quarters · filed 2025-11-07 | $1.31M 10-Q · filed 2025-11-07 | $1.81M derived: sum of 4 quarters · filed 2025-11-07 | |||
| 2024-06-30 | $490.00K 10-Q · filed 2025-08-08 | $875.00K 10-Q · filed 2025-08-08 | $1.38M derived: sum of 3 quarters · filed 2025-08-08 | $2.04M derived: sum of 4 quarters · filed 2025-08-08 | |||
| 2024-03-31 | $385.00K 10-Q · filed 2025-05-09 | $894.00K derived: sum of 2 quarters · filed 2025-05-09 | $1.55M derived: sum of 3 quarters · filed 2025-05-09 | $2.18M derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.17M derived: sum of 2 quarters · filed 2025-03-31 | $1.79M derived: sum of 3 quarters · filed 2025-03-31 | $2.34M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | $661.00K 10-Q · filed 2024-11-06 | $1.28M derived: sum of 2 quarters · filed 2024-11-06 | $1.83M 10-Q · filed 2024-11-06 | $2.31M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | $623.00K 10-Q · filed 2024-08-12 | $1.17M 10-Q · filed 2024-08-12 | $1.64M derived: sum of 3 quarters · filed 2024-08-12 | $1.84M derived: sum of 4 quarters · filed 2024-08-12 | |||
| 2023-03-31 | $547.00K 10-Q · filed 2024-05-08 | $1.02M derived: sum of 2 quarters · filed 2024-05-08 | $1.22M derived: sum of 3 quarters · filed 2024-05-08 | $1.28M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $672.00K derived: sum of 2 quarters · filed 2024-04-10 | $732.00K derived: sum of 3 quarters · filed 2024-04-10 | $781.00K 10-K · filed 2024-04-10 | |||
| 2022-09-30 | $198.00K 10-Q · filed 2023-11-08 | $258.00K derived: sum of 2 quarters · filed 2023-11-08 | $307.00K 10-Q · filed 2023-11-08 | $349.00K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $60.00K 10-Q · filed 2023-08-09 | $109.00K 10-Q · filed 2023-08-09 | $151.00K derived: sum of 3 quarters · filed 2023-08-09 | $165.00K derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $49.00K 10-Q · filed 2023-05-10 | $91.00K derived: sum of 2 quarters · filed 2023-05-10 | $105.00K derived: sum of 3 quarters · filed 2023-05-10 | $112.00K derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $56.00K derived: sum of 2 quarters · filed 2023-03-31 | $63.00K derived: sum of 3 quarters · filed 2023-03-31 | $72.00K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $14.00K 10-Q · filed 2022-11-14 | $21.00K derived: sum of 2 quarters · filed 2022-11-14 | $30.00K 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $7.00K 10-Q · filed 2022-08-11 | $8.53K 10-Q · filed 2021-08-09 | $16.00K 10-Q · filed 2022-08-11 | $31.65K 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $9.00K 10-Q · filed 2022-05-11 | $23.11K 10-Q · filed 2021-05-24 | |||||
| 2020-12-31 | $5.89K 10-K/A · filed 2021-05-14 | $91.00K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |